Neuraxis Inc NRXS

$7.11 -0.06 (-0.84%)

Valuation

Market cap
89,287,000
Revenue TTM
$3,570,000
Net income TTM
$-7,800,000
PE ratio
0.00
Forward PE
—
Profit margin
-218.49%
Debt to equity
0.00

Trading

Volume
47,400
Avg volume
119,450
Day's range
$7.01 – $7.49
Shares out
12,558,000
Stochastic %K
15%
Beta
1.38
Analysts
Strong Sell
Price target
$13.00

Price

Company profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and as...

Show more

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Industry
Biotechnology
Sector
Healthcare
Phone
812 689 0791
Website
https://neuraxis.com
Address
11611 North Meridian St, Suite 330, Carmel, United States

Latest news

Stocktwits

stockinvestor102 Sep 29, 4:57 PM
$NRXS https://ir.neuraxis.com/neuraxis-positions-for-next-phase-of-commercial-growth-with-appointment-of-craig-blanchard-as-chief-commercial-officer/
0 replies
Tennis_4567 Sep 27, 12:07 PM
$NRXS another conference on Tuesday. People tend to buy when they hear the NRXS story for the first time. I also expect another coverage win in the next 6 -8 weeks.
0 replies
iAccess_Alpha Sep 25, 2:11 PM
Missed $NRXS live? Access the presentation replay: https://www.webcaster5.com/Webcast/Page/3171/54417 #microcap #smallcap #investing
0 replies
cleverrox Sep 25, 12:17 PM
New Article for $NRXS Banging the Table on NeurAxis Quick Briefing: MCO Portfolio Stock NeurAxis (NRXS) @ Inflection Point https://microcapopportunities.substack.com/p/banging-the-table-on-neuraxis
0 replies
Finnish_boy Sep 25, 9:07 AM
$NRXS We will see Q3 post earnings dip, how big and quick, depends on where SP trades a moment before the Q3 report is out.
0 replies
Finnish_boy Sep 25, 9:04 AM
$NRXS Q3 results final hurdle. Revenue growth minimal and big one-time cost. After Q3 results i expect huge run up by the end of 2027. Additional coverage is must, but luckily very likely🤑💪🏼
0 replies
Tennis_4567 Sep 22, 12:54 PM
$NRXS can’t tag him here as he blocked me, but Iooks like his dogmatic assertion that they won’t get more insurance coverage continues to be wrong,…
1 replies
JFais Sep 19, 6:59 PM
$NRXS (NP) Interesting medical device play, neuromodulation for GI disorders (am a fan of non-drug options) Expanded coverage brings PENFS to >120M lives (caveat= hospitals can be slow adopters) Osmium (veteran in the space) w/few thoughts on CEO from ongoing Chat discussion
1 replies